IL18 and neoplasm: GzB-IL18 enhanced re-stimulation capacity on MDA-MB-468 or BxPC3 tumor monolayers (Figure S4G), accompanied by increased CAR T cell expansion (Figure S4H) and sustained IFN-γ production (Figure S4I).